Pharma Stock Roundup PFEs 2025 Outlook, MRK ABBVs MA Deals
| TEVA Stock | USD 20.94 0.55 2.56% |
About 61% of Teva Pharma's investor base is looking to short. The analysis of overall sentiment of trading Teva Pharma Industries stock suggests that many investors are alarmed at this time. The current market sentiment, together with Teva Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharma Industries stock news signals to limit their universe of possible portfolio assets.
Teva |
PFE issues its financial guidance for 2025. MRK and ABBV announce MA deals. SNYTEVAs IBD drug succeeds in a phase IIb study.
Read at zacks.com
 |
Teva Pharma Fundamental Analysis
We analyze Teva Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teva Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teva Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Teva Pharma is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Teva Pharma Industries Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teva Pharma stock to make a market-neutral strategy. Peer analysis of Teva Pharma could also be used in its relative valuation, which is a method of valuing Teva Pharma by comparing valuation metrics with similar companies.
Peers
Teva Pharma Related Equities
| LFCR | Lifecore Biomedical | 8.45 | ||||
| SHPH | Shuttle Pharmaceuticals | 1.16 | ||||
| BHC | Bausch Health | 0.64 | ||||
| ZTS | Zoetis | 1.03 | ||||
| ELAN | Elanco Animal | 1.04 | ||||
| SNDL | SNDL | 2.13 | ||||
| TAK | Takeda Pharmaceutical | 2.19 | ||||
| VTRS | Viatris | 2.42 | ||||
| CRON | Cronos | 2.46 | ||||
| HLN | Haleon Plc | 4.11 | ||||
| ACB | Aurora Cannabis | 6.56 | ||||
| CGC | Canopy Growth | 7.89 | ||||
| TLRY | Tilray | 10.22 |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |